Publications by authors named "Marc A Rodwin"

Claim this Profile
N
Negotiating Medicare Drug Prices: A New Attempt to Control Purchase Prices.
Marc A Rodwin

J Law Med Ethics· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinician Conflicts of Interest at the Cleveland Clinic: The Context and Functions of Disclosure Policy and What Remains Unknown.
Marc A Rodwin

J Law Med Ethics· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing US Pharmaceutical Policy and Pricing Reform Legislation in Light of European Price and Cost Control Strategies.
Marc A Rodwin

J Health Polit Policy Law· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The No Surprises Act: A Conservative Band-Aid to Protect Business as Usual.
Marc A Rodwin, Alan Sager

Int J Health Serv· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WHO's Attempt to Navigate Commercial Influence and Conflicts of Interest in Nutrition Programs While Engaging With Non-State Actors: Reflections on WHO Guidance for Nation States Comment on "Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool".
Marc A Rodwin

Int J Health Policy Manag· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
German Pharmaceutical Pricing: Lessons for the United States.
Marc A Rodwin, Sara Gerke

Int J Health Serv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Pricing, Competition, And Regulation.
Marc A Rodwin

Health Aff (Millwood)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common Pharmaceutical Price and Cost Controls in the United Kingdom, France, and Germany: Lessons for the United States.
Marc A Rodwin

Int J Health Serv· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "The use of 'added benefit' to determine the price of new anti-cancer drugs in France, 2004-2017" [Eur J Canc 145 (2021) 11-18].
Marc A Rodwin, Julien Mancini, Ségolène Duran, Anne-Céline Jalbert, Patrice Viens

Eur J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How the United Kingdom Controls Pharmaceutical Prices and Spending: Learning From Its Experience.
Marc A Rodwin

Int J Health Serv· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of 'added benefit' to determine the price of new anti-cancer drugs in France, 2004-2017.
Marc A Rodwin, Julien Mancini, Ségolène Duran, Anne-Céline Jalbert, Patrice Viens

Eur J Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical Price and Spending Controls in France: Lessons for the United States.
Marc A Rodwin

Int J Health Serv· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathways to independence: towards producing and using trustworthy evidence.
Ray Moynihan, Lisa Bero, Sue Hill, Minna Johansson, Joel Lexchin, Marc A Rodwin

BMJ· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conflicts of Interest in Human Subject Research: The Insufficiency of U.S. and International Standards.
Marc A Rodwin

Am J Law Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attempts to redefine conflicts of interest.
Marc A Rodwin

Account Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why the Medical Malpractice Crisis Persists Even When Malpractice Insurance Premiums Fall.
Marc A Rodwin, Justin Silverman, David Merfeld

Health Matrix Clevel· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do We Need Stronger Sanctions to Ensure Legal Compliance By Pharmaceutical Firms?
Marc A Rodwin

Food Drug Law J· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction: Institutional corruption and the pharmaceutical policy.
Marc A Rodwin

J Law Med Ethics· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five un-easy pieces of pharmaceutical policy reform.
Marc A Rodwin

J Law Med Ethics· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rooting out institutional corruption to manage inappropriate off-label drug use.
Marc A Rodwin

J Law Med Ethics· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conflicts of interest, institutional corruption, and pharma: an agenda for reform.
Marc A Rodwin

J Law Med Ethics· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial data as a public good.
Marc A Rodwin, John D Abramson

JAMA· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan.
Marc A Rodwin

J Law Med Ethics· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why we need health care reform now.
Marc A Rodwin

J Health Polit Policy Law· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New standards for medical review organizations: holding them and health plans accountable for their decisions.
Marc A Rodwin

Health Aff (Millwood)· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis